Results 241 to 250 of about 1,254,005 (293)
Some of the next articles are maybe not open access.

An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines

Veterinary Microbiology, 1996
A comparative study on the efficacy of 3 bovine herpesvirus 1 (BHV1) marker vaccines was carried out. An attenuated gE-negative vaccine, an inactivated gE-negative vaccine and an experimental gD-subunit vaccine were tested twice in a vaccination-challenge experiment in cattle.
Bosch, J.C.   +3 more
openaire   +3 more sources

Markers and Vaccines

1978
Publisher Summary This chapter is concerned with virus vaccines and their genetically conditioned markers. For many years, virus vaccines have been in fact the only effective means for reducing the morbidity of virus infections, and thus far biogenic, semisynthetic, and synthetic antiviral substances have failed to give satisfactory results. Although
openaire   +2 more sources

Tumor Antigens as Surrogate Markers and Targets for Therapy and Vaccines

2006
There are a large number of tumor antigens, which may either be specific to the tumor or inappropriately expressed or processed (tumor-associated antigen, TAA). Over the last few years, hundreds of new TAAs have been identified. Some of these represent good targets for both passive (antibody based) and active (vaccine based) therapies.
Dalgleish, A, Pandha, H
openaire   +4 more sources

H5N1 influenza marker vaccine for serological differentiation between vaccinated and infected chickens

Biochemical and Biophysical Research Communications, 2008
Using plasmid-based reverse genetics, we generated a molecularly altered virus, H5N1/PR8-5B19, containing modified HA and NA genes from A/Goose/Guangdong/1/96 (GS/GD/1/96). In the H5N1/PR8-5B19 virus, the HA cleavage site was modified to resemble that of low-pathogenic avian strains and a portion of the NA stalk region was replaced by the ...
Chengjun, Li   +9 more
openaire   +2 more sources

Vaccination markers: designing unique antigens to be added to vaccines to differentiate between natural infection and vaccination

Vaccine, 2005
Some important vaccines, including ones against tuberculosis (Tb) and foot-and-mouth disease (FMD), are not used in many developed countries because there is no simple way to differentiate between vaccine-induced immunity and infection. Eliminating major protein antigens has not succeeded in the cases of Tb, FMD and some other vaccine preparations ...
openaire   +2 more sources

Effect of influenza vaccine on markers of inflammation and lipid profile

Journal of Laboratory and Clinical Medicine, 2005
Despite wide use of the influenza vaccine, relatively little is known about its effect on the measurement of inflammatory markers. Because inflammatory markers such as C-reactive protein (CRP) are increasingly being used in conjunction with lipids for the clinical assessment of cardiovascular disease and in epidemiologic studies, we evaluated the ...
Michael Y, Tsai   +7 more
openaire   +2 more sources

Using Infection Markers as a Vaccine against Malware Attacks

2012 IEEE International Conference on Green Computing and Communications, 2012
Malware is used by criminals for financial gains, espionage and sabotage, and their code and evasion techniques become increasingly complex and sophisticated. This means it takes longer for security researchers to analyse a malware and develop detection and removal routines, increasing the danger of critical systems becoming infected.
André Wichmann, Elmar Gerhards-Padilla
openaire   +1 more source

Novel marker vaccines against classical swine fever

Vaccine, 2007
Classical swine fever (CSF) is one of the most devastating epizootic diseases of pigs worldwide. For eradication and control purposes, CSF vaccination is an important tool, and efficacious and safe attenuated vaccines have been available for many decades (for example, the C-strain vaccines).
Martin, Beer   +3 more
openaire   +2 more sources

Laboratory markers for over-attenuation of mumps vaccine virus

Vaccine, 1988
The properties of mumps vaccine virus (Leningrad-3 strain) gradually changed upon passaging in quail embryo fibroblasts, the substrate normally used for mumps vaccine production in the USSR. Alterations were extremely noticeable in the over-attenuated (38th passage) virus variant, and involved (a) poor, if any, antibody response in guinea-pigs, (b ...
, Boriskin YuS   +4 more
openaire   +2 more sources

Experiences with two BHV1 marker vaccines

The Bovine Practitioner, 1997
Both marker vaccines tested were deleted vaccines, one had a gG, the other a gE deletion. The gG deleted vaccine was inactivated the gE deleted vaccine had a live and an inactivated form. The object of the trial was to evaluate these vaccines in heifers and calves. Twenty young heifers were used for the inactivated deleted vaccines and 16 four week old
openaire   +1 more source

Home - About - Disclaimer - Privacy